Krsnaa Diagnostics Q1 FY27 Results: Revenue Jumps 22%, Margins Face Pressure

Revenue from Operations: Rs 235.5 crore (Q1 FY27) vs Rs 193.0 crore (Q1 FY26)
EBITDA Margin: 25% (Q1 FY27) vs 27% (Q1 FY26)

Reader Takeaway: Strong revenue growth is offset by short-term margin pressure from new project expenses.

What just happened

Krsnaa Diagnostics reported a 22% year-on-year increase in revenue from operations for the first quarter of FY27, reaching Rs 235.5 crore. The company also saw a significant 64% rise in its retail revenue to Rs 19.3 crore. However, its EBITDA margin moderated to 25% compared to 27% in the same period last year.

Why this matters

The revenue growth indicates continued expansion and operational progress, particularly with new public-private partnership (PPP) projects. The retail business also shows strong momentum. The dip in margins, however, requires investor attention, as it stems from upfront costs associated with scaling new ventures.

The backstory

Krsnaa Diagnostics is a major player in medical diagnostics services, focusing on radiology and pathology. The company has been expanding its network, particularly through large-scale government and PPP projects alongside its retail business.

What changes now

The Rajasthan PPP project, a key growth driver, has transitioned from implementation to operational status, contributing Rs 26 crore in revenue. Further expansion is noted in Himachal Pradesh and Maharashtra. The management expects margins to improve sequentially as new projects reach optimal utilization.

Risks to watch

Continued pressure on margins due to high initial costs for new projects is a key concern. Additionally, the company is monitoring the recovery of outstanding payments from the governments of Himachal Pradesh and Karnataka.

Peer comparison

While specific peer results for the same quarter are not detailed here, Krsnaa Diagnostics operates in a competitive diagnostic services market. Its focus on large-scale PPP projects differentiates its operational model compared to smaller, purely retail-focused diagnostic chains.

Context metrics (time-bound)

• EBITDA in Q1 FY27 stood at Rs 58.8 crore.
• Retail revenue contributed 9% of total revenue in Q1 FY27.
• Over 4,000 personnel have been onboarded for the Rajasthan project.

What to track next

Investors will be looking for sequential improvement in EBITDA margins in the upcoming quarters as new projects mature. The pace of receivable collections from government entities and the ongoing scaling of the retail business will also be critical factors.